Latest filing published 25 Sept 2018 for Atara Biotherapeutics, Inc., €750k.
Filing timeline
BuySaleInsider track record
Gad Soffer: trading record in brief
Gad Soffer discloses dealings in Atara Biotherapeutics, Inc. to SEC (Form 4). Between 16 January 2015 and 22 September 2018, the trades on record add up to 57 filings.
The open-market record consists of 23 sales worth €2.3M, with no purchase. The rest of the record consists of 12 share grants and 22 option exercises.
The newest entry dates from 25 September 2018: a share grant of €750k, in Atara Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gad Soffer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,158 shares@ US$39.8563.7% of flowCommon StockSEC:0001209191-18-052145:0
- 382 shares@ US$35.901.0% of flowCommon StockSEC:0001209191-18-047221:0
- 382 shares@ US$45.900.6% of flowCommon StockSEC:0001209191-18-030725:0
- 2,764 shares0Common StockSEC:0001209191-18-011667:0
- 1,456 shares@ US$47.052.3% of flowCommon StockSEC:0001209191-18-011667:1
- 4,169 shares@ US$41.705.9% of flowCommon StockSEC:0001209191-18-009406:0
- 17,500 shares0Common StockSEC:0001209191-18-008511:0
- 3,987 shares@ US$35.804.8% of flowCommon StockSEC:0001209191-18-008511:1
- 4,146 shares0Common StockSEC:0001209191-17-061621:0
- 7,000 shares@ US$15.003.7% of flowCommon StockSEC:0001209191-17-061621:1
- 7,000 shares@ US$15.003.7% of flowCommon StockSEC:0001209191-17-049451:0
- 2,464 shares@ US$14.531.3% of flowCommon StockSEC:0001209191-17-049451:2
- 4,145 shares0Common StockSEC:0001209191-17-049451:1
- 7,000 shares@ US$15.134.0% of flowCommon StockSEC:0001209191-17-033185:0
- 5,674 shares@ US$15.193.2% of flowCommon StockSEC:0001209191-17-033185:3
- 6,410 shares0Common StockSEC:0001209191-17-033185:1
- 4,146 shares0Common StockSEC:0001209191-17-033185:2
- 2,500 shares@ US$20.002.0% of flowCommon StockSEC:0001209191-17-020262:0
- 7,000 shares@ US$15.224.2% of flowCommon StockSEC:0001209191-17-011766:0
- 7,273 shares@ US$15.624.4% of flowCommon StockSEC:0001209191-17-011766:3
- 9,616 shares0Common StockSEC:0001209191-17-011766:1
- 4,146 shares0Common StockSEC:0001209191-17-011766:2
- 5,874 shares@ US$15.423.5% of flowCommon StockSEC:0001209191-17-010165:0
- 400 shares@ US$16.130.2% of flowCommon StockSEC:0001209191-17-010165:1
- 45,000 shares0Common StockSEC:0001209191-17-008824:0
25 of 57 declarations
